相关实验视频
Updated: May 5, 2026

13:18
Single Oocyte Bisulfite Mutagenesis
Published on: June 27, 2012
14.0K
用于治疗未知位置怀孕的单剂量和双剂量甲状腺素治疗方案的比较
Magdalena M Piróg1, Anna Pulka1, Przemysław Urbaniec1
1Department of Gynaecological Endocrinology, Jagiellonian University Medical College, Krakow, Poland.
概括
单剂量和双剂量甲状腺素 (MTX) 方案显示,在治疗未知位置怀孕 (PUL) 时的成功率相似. 这两种方案都是有效的,特别是对于初始水平较低的人类胆管性腺激素水平的女性.
科学领域:
- 妇科 妇科医生 妇科
- 生殖内分泌学 生殖内分泌学
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲托雷克萨特 (MTX) 是异胎妊娠的标准治疗方法.
- 未知位置的怀孕 (PUL) 提出了诊断和治疗方面的挑战.
- 评估PUL的MTX协议对于优化患者护理至关重要.
研究的目的:
- 为了比较单剂量与双剂量MTX协议在治疗PUL中的疗效.
- 评估PUL的MTX治疗的治疗成功率和持续时间.
- 确定可能从特定的MTX协议中获益更多的患者子组.
主要方法:
- 对血液动力学稳定的女性进行了回顾性研究,她们患有PUL.
- 单剂量和双剂量MTX组之间的结果比较.
- 主要结局:非手术治疗成功率.
- 二次结果:时间达到足够的β-人类胆管性腺激素 (β-hCG) 降低.
主要成果:
- 在211名患有PUL的女性中,总体成功率为89.1%,达到89.1%.
- 单剂量 (93%) 和双剂量 (95%) MTX 方案的治疗成功率相对较高.
- 在女性初始β-hCG较低 (<2000 mIU/ml) 的女性中观察到更高的疗效,不管协议如何.
- 单剂量MTX导致住院时间缩短了一天.
结论:
- 单剂和双剂MTX方案在PUL治疗中显示出可比的疗效和安全性.
- 这两种方案都适用于患有PUL和初始β-hCG<2000mIU/ml的女性.
- 根据患者的因素和所需结果,可以根据个人选择方案.
相关概念视频
Bioavailability Study Design: Single Versus Multiple Dose Studies
388
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
388
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
398
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
398
Therapeutic Drug Monitoring: Affecting Factors
438
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
438

